SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000882104-18-000028
Filing Date
2018-05-09
Accepted
2018-05-09 16:03:48
Documents
102
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pdli-2018033110qdoc.htm 10-Q 1414466
2 RATIO OF EARNINGS TO FIXED CHARGES pdli-2018033110qex121.htm EX-12.1 60156
3 CERTIFICATION pdli-2018033110qex311.htm EX-31.1 10968
4 CERTIFICATION pdli-2018033110qex312.htm EX-31.2 11259
5 CERTIFICATION pdli-2018033110qex321.htm EX-32.1 14266
12 pdllogo.jpg GRAPHIC 123123
  Complete submission text file 0000882104-18-000028.txt   10053265

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdli-20180331.xml EX-101.INS 2150889
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20180331.xsd EX-101.SCH 97915
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20180331_cal.xml EX-101.CAL 115688
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20180331_def.xml EX-101.DEF 528348
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20180331_lab.xml EX-101.LAB 887054
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20180331_pre.xml EX-101.PRE 671636
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 18818221
SIC: 2836 Biological Products, (No Diagnostic Substances)